Annual Retained Earnings
-$391.83 M
-$5.57 M-1.44%
December 31, 2023
Summary
- As of March 9, 2025, TTNP annual retained earnings is -$391.83 million, with the most recent change of -$5.57 million (-1.44%) on December 31, 2023.
- During the last 3 years, TTNP annual retained earnings has fallen by -$24.55 million (-6.68%).
- TTNP annual retained earnings is now -1155.87% below its all-time high of -$31.20 million, reached on December 31, 1995.
Performance
TTNP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$395.75 M
-$763.00 K-0.19%
September 30, 2024
Summary
- As of March 9, 2025, TTNP quarterly retained earnings is -$395.75 million, with the most recent change of -$763.00 thousand (-0.19%) on September 30, 2024.
- Over the past year, TTNP quarterly retained earnings has dropped by -$3.92 million (-1.00%).
- TTNP quarterly retained earnings is now -1168.42% below its all-time high of -$31.20 million, reached on December 31, 1995.
Performance
TTNP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
TTNP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.4% | -1.0% |
| 3 y3 years | -6.7% | -4.5% |
| 5 y5 years | -17.8% | -7.0% |
TTNP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.2% | at low | -5.2% | at low |
| 5 y | 5-year | -12.3% | at low | -13.4% | at low |
| alltime | all time | -1155.9% | at low | -1168.4% | at low |
Titan Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$395.75 M(+0.2%) |
| Jun 2024 | - | -$394.98 M(+0.5%) |
| Mar 2024 | - | -$392.89 M(+0.3%) |
| Dec 2023 | -$391.83 M(+1.4%) | -$391.83 M(+0.5%) |
| Sep 2023 | - | -$389.86 M(+0.1%) |
| Jun 2023 | - | -$389.52 M(+0.4%) |
| Mar 2023 | - | -$387.94 M(+0.4%) |
| Dec 2022 | -$386.26 M(+2.7%) | -$386.26 M(+0.7%) |
| Sep 2022 | - | -$383.69 M(+0.7%) |
| Jun 2022 | - | -$381.06 M(+0.7%) |
| Mar 2022 | - | -$378.60 M(+0.7%) |
| Dec 2021 | -$376.06 M(+2.4%) | -$376.06 M(+0.7%) |
| Sep 2021 | - | -$373.51 M(+0.5%) |
| Jun 2021 | - | -$371.60 M(+0.5%) |
| Mar 2021 | - | -$369.92 M(+0.7%) |
| Dec 2020 | -$367.28 M(+5.2%) | -$367.28 M(+0.8%) |
| Sep 2020 | - | -$364.19 M(+1.4%) |
| Jun 2020 | - | -$359.26 M(+1.3%) |
| Mar 2020 | - | -$354.62 M(+1.6%) |
| Dec 2019 | -$349.04 M(+4.9%) | -$349.04 M(+1.1%) |
| Sep 2019 | - | -$345.10 M(+0.8%) |
| Jun 2019 | - | -$342.29 M(+1.5%) |
| Mar 2019 | - | -$337.10 M(+1.4%) |
| Dec 2018 | -$332.58 M(+2.9%) | -$332.58 M(+1.1%) |
| Sep 2018 | - | -$329.07 M(+0.7%) |
| Jun 2018 | - | -$326.75 M(+0.3%) |
| Mar 2018 | - | -$325.88 M(+0.8%) |
| Dec 2017 | -$323.27 M(+4.6%) | -$323.27 M(+1.1%) |
| Sep 2017 | - | -$319.61 M(+1.3%) |
| Jun 2017 | - | -$315.42 M(+1.1%) |
| Mar 2017 | - | -$311.97 M(+1.0%) |
| Dec 2016 | -$308.96 M(-1.6%) | -$308.96 M(+0.8%) |
| Sep 2016 | - | -$306.64 M(+0.9%) |
| Jun 2016 | - | -$304.02 M(-3.8%) |
| Mar 2016 | - | -$315.94 M(+0.6%) |
| Dec 2015 | -$314.10 M(+3.7%) | -$314.10 M(+0.7%) |
| Sep 2015 | - | -$311.81 M(+0.6%) |
| Jun 2015 | - | -$310.00 M(+0.7%) |
| Mar 2015 | - | -$307.72 M(+1.6%) |
| Dec 2014 | -$302.82 M(+0.8%) | -$302.82 M(+0.2%) |
| Sep 2014 | - | -$302.35 M(-0.2%) |
| Jun 2014 | - | -$303.06 M(+0.3%) |
| Mar 2014 | - | -$302.22 M(+0.6%) |
| Dec 2013 | -$300.42 M(-3.1%) | -$300.42 M(+0.1%) |
| Sep 2013 | - | -$300.21 M(+0.4%) |
| Jun 2013 | - | -$299.06 M(-1.7%) |
| Mar 2013 | - | -$304.13 M(-1.9%) |
| Dec 2012 | -$310.13 M(+5.1%) | -$310.13 M(+0.1%) |
| Sep 2012 | - | -$309.85 M(+2.7%) |
| Jun 2012 | - | -$301.83 M(+0.6%) |
| Mar 2012 | - | -$300.11 M(+1.8%) |
| Dec 2011 | -$294.95 M(+5.4%) | -$294.95 M(+1.0%) |
| Sep 2011 | - | -$292.05 M(+0.3%) |
| Jun 2011 | - | -$291.25 M(+2.5%) |
| Mar 2011 | - | -$284.26 M(+1.6%) |
| Dec 2010 | -$279.75 M | -$279.75 M(+1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | -$275.45 M(+0.1%) |
| Jun 2010 | - | -$275.06 M(+0.7%) |
| Mar 2010 | - | -$273.22 M(+0.1%) |
| Dec 2009 | -$272.91 M(+13.0%) | -$272.91 M(+4.6%) |
| Sep 2008 | - | -$260.90 M(+2.3%) |
| Jun 2008 | - | -$255.00 M(+3.1%) |
| Mar 2008 | - | -$247.31 M(+2.4%) |
| Dec 2007 | -$241.59 M(+7.9%) | -$241.59 M(+2.6%) |
| Sep 2007 | - | -$235.38 M(+1.9%) |
| Jun 2007 | - | -$231.05 M(+1.6%) |
| Mar 2007 | - | -$227.52 M(+1.6%) |
| Dec 2006 | -$223.94 M(+7.6%) | -$223.94 M(+1.5%) |
| Sep 2006 | - | -$220.68 M(+2.0%) |
| Jun 2006 | - | -$216.34 M(+1.6%) |
| Mar 2006 | - | -$212.91 M(+2.3%) |
| Dec 2005 | -$208.21 M(+12.1%) | -$208.21 M(+2.0%) |
| Sep 2005 | - | -$204.16 M(+3.2%) |
| Jun 2005 | - | -$197.78 M(+3.0%) |
| Mar 2005 | - | -$192.04 M(+3.4%) |
| Dec 2004 | -$185.75 M(+16.3%) | -$185.75 M(+4.4%) |
| Sep 2004 | - | -$177.95 M(+3.7%) |
| Jun 2004 | - | -$171.68 M(+3.3%) |
| Mar 2004 | - | -$166.12 M(+4.0%) |
| Dec 2003 | -$159.74 M(+23.0%) | -$159.74 M(+7.0%) |
| Sep 2003 | - | -$149.23 M(+4.3%) |
| Jun 2003 | - | -$143.06 M(+4.9%) |
| Mar 2003 | - | -$136.38 M(+5.0%) |
| Dec 2002 | -$129.85 M(+27.7%) | -$129.85 M(+7.4%) |
| Sep 2002 | - | -$120.95 M(+6.4%) |
| Jun 2002 | - | -$113.65 M(+6.6%) |
| Mar 2002 | - | -$106.62 M(+4.9%) |
| Dec 2001 | -$101.67 M(+20.7%) | -$101.67 M(+6.6%) |
| Sep 2001 | - | -$95.35 M(+5.3%) |
| Jun 2001 | - | -$90.56 M(+2.1%) |
| Mar 2001 | - | -$88.72 M(+5.4%) |
| Dec 2000 | -$84.21 M(+28.8%) | -$84.21 M(+5.0%) |
| Sep 2000 | - | -$80.20 M(+12.2%) |
| Jun 2000 | - | -$71.49 M(+3.5%) |
| Mar 2000 | - | -$69.07 M(+5.6%) |
| Dec 1999 | -$65.40 M(+20.9%) | -$65.40 M(+4.6%) |
| Sep 1999 | - | -$62.50 M(+4.2%) |
| Jun 1999 | - | -$60.00 M(+5.4%) |
| Mar 1999 | - | -$56.90 M(+5.2%) |
| Dec 1998 | -$54.10 M(+24.4%) | -$54.10 M(+6.3%) |
| Sep 1998 | - | -$50.90 M(+5.8%) |
| Jun 1998 | - | -$48.10 M(+4.8%) |
| Mar 1998 | - | -$45.90 M(+5.5%) |
| Dec 1997 | -$43.50 M(-1.4%) | -$43.50 M(-23.6%) |
| Sep 1997 | - | -$56.90 M(+7.4%) |
| Jun 1997 | - | -$53.00 M(-7.5%) |
| Mar 1997 | - | -$57.30 M(+29.9%) |
| Dec 1996 | -$44.10 M(+41.3%) | -$44.10 M(+10.0%) |
| Sep 1996 | - | -$40.10 M(+7.5%) |
| Jun 1996 | - | -$37.30 M(+7.5%) |
| Mar 1996 | - | -$34.70 M(+11.2%) |
| Dec 1995 | -$31.20 M | -$31.20 M |
FAQ
- What is Titan Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual retained earnings year-on-year change?
- What is Titan Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly retained earnings year-on-year change?
What is Titan Pharmaceuticals annual retained earnings?
The current annual retained earnings of TTNP is -$391.83 M
What is the all time high annual retained earnings for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual retained earnings is -$31.20 M
What is Titan Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, TTNP annual retained earnings has changed by -$5.57 M (-1.44%)
What is Titan Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of TTNP is -$395.75 M
What is the all time high quarterly retained earnings for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly retained earnings is -$31.20 M
What is Titan Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, TTNP quarterly retained earnings has changed by -$3.92 M (-1.00%)